After Bicara Therapeutics Inc (NASDAQ: BCAX) Surges -111.48% From Highs, What Will It Look Like?

IPW

During the last session, Bicara Therapeutics Inc (NASDAQ:BCAX)’s traded shares were 0.7 million. At the end of the trading day, the stock’s price was $16.55, reflecting an intraday gain of 5.08% or $0.8. The 52-week high for the BCAX share is $28.09, that puts it down -69.73 from that peak though still a striking 32.93% gain since the share price plummeted to a 52-week low of $11.10. The company’s market capitalization is $900.58M, and the average trade volume was 446.74K shares over the past three months.

Bicara Therapeutics Inc (NASDAQ:BCAX) trade information

Bicara Therapeutics Inc (BCAX) registered a 5.08% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.08% in intraday trading to $16.55, hitting a weekly high. The stock’s 5-day price performance is 24.44%, and it has moved by 30.11% in 30 days.

The consensus price target of analysts on Wall Street is $35, which implies an increase of 52.71% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35 and $35 respectively. As a result, BCAX is trading at a discount of -111.48% off the target high and -111.48% off the low.

While earnings are projected to return 16.24% in 2025, the next five years will return -9.13% per annum.

BCAX Dividends

Bicara Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Bicara Therapeutics Inc (BCAX) shares are Price (T.Rowe) New Horizons Fund and iShares Russell 2000 ETF . Data provided on Dec 31, 2024 indicates that Price (T.Rowe) New Horizons Fund owns about 589.03 shares. This amounts to just over 1.08 percent of the company’s overall shares, with a $9.75 million market value. The same data shows that the other fund manager holds slightly less at 490.05, or about 0.90% of the stock, which is worth about $8.11 million.